Symbol: 
Dynamic Watchlist

Trading Activities Reports
OTCBB News
OTCBB News
OTC Equity Short Interest
SEC 605 Report
Investor Info.
Issuer Info.
Vendor Info.
OTCBB Rules
About OTCBB

 

Clenergen Corp.
Symbol:  CRGE


Click here for a printable version
Business Summary: Clenergen Corporation installs, owns and operates Distributed Environmental Power Systems and applies plant science to the cultivation of proprietary biomass feedstocks in order to provide sustainable supplies of clean energy to regional, independent clients and national grids.
 
Address
  6165 NW 123rd Lane
  Coral Springs , FL 33076
  Phone: 866-640-8818
  Website: http://www.clenergen.com
Auditor
  Holtz Rubenstein Reminick LLP
Transfer Agent
  Holladay Stock Transfer, Inc.
Employees:  44
ShareHolders:  112
Founded:  2005
Domicile:  Nevada
 
  S & P Disclaimer
 

Clenergen Corp.
Symbol:  CRGE


Click here for a printable version
Clenergen Corporation, following the November 2009 acquisition of Clenergen Corporation Limited, an advanced stage development company, installs, owns and operates Distributed Environmental Power Systems and applies plant science to the cultivation of proprietary biomass feedstocks in order to provide sustainable supplies of clean energy to regional, independent clients and national grids. The company has developed a program to produce high-density, short-rotation biomass crops on a commercial scale at a cost of production equivalent to or less than the price of coal (measured in energy terms -- MMBtu) using a proprietary integrated farming model, and to produce power, steam, hydrogen, transport fuel, fertilizers, pesticides, chemicals and other products through advanced gasification and steam technologies. Clenergen's projects are grouped by geographic location. Existing and proposed projects are located in India, Ghana, Russia, Guyana, Philippines, the United States, Libya and Southern Africa. Clenergen has entered into a joint venture with Enhanced Biofuels and Technologies India Private Limited (EBTI) and formed Biomass2Biopower Limited for the purpose of research and development of indigenous species of trees (Eucalyptus, Casuarinas and Vanashree), as well as developing the company's own pesticides and fertilizers for use on its plantations worldwide. Clenergen intends to set up two power projects simultaneously, 16MW/Hr in Tamilnadu and 64MW/Hr in Karnataka, in the first phase of its operations in India. Clenergen plans to commence full-scale operation of a 1.5MW facility in Tuticorin, Tamilnadu in December 2009. Power Trading Corporation of India Limited has agreed to expand the company's existing 71MW/Hr contract by an additional 10MW/Hr. The by-product from the biomass power plant is compost, which can be converted into a high-quality manure and used as fertilizer on the plantation projects the company has identified in India. Clenergen has entered into a 5,000-acre sublease and retains the right to sublease an additional 145,000 acres of contiguous savannah lands in Guyana. According to the company, these lands are capable of supplying 6 million tonnes of wood chips at a very low cost of production. Clenergen is in the early stages of testing its wood chips with gas to liquid technology with a view to possibly licensing this technology for installation in Guyana for future export of ASTM standard transport fuels to the United States.
History:  INCORPORATED in Nevada May 2, 2005, as American Bonanza Resources Corp.; name changed to Clenergen Corp. Mar. 19, 2009. On Nov. 5, 2009, the company acquired all of the issued and outstanding Common shares of Clenergen Corporation Limited (Clenergen UK). At the closing, 5,865,175 Common shares of the company were issued to former stockholders of Clenergen UK. On Aug. 4, 2009, the company issued 31,847,968 Common shares to the same shareholders of Clernergen UK for future consulting services. Clenergen Corporation Limited was incorporated on Mar. 4, 2009.
 
Subsidiaries:
Clenergen Biopower Corporation
Clenergen Corporation Limited
Clenergen India Private Limited
 
 
 
 
  S & P Disclaimer
 

Clenergen Corp.
Symbol:  CRGE


Click here for a printable version

Management
OfficersPosition
 Arvind  PandalaiChairman
 Robert  KohnVice Chairman
 Mark  QuinnPresident & Chief Executive Officer
 Dale  ShepherdChief Financial Officer
 Jessica  HatfieldExec VP
 Mark  QuinnInvestor Relations Contact

Directors
 Jack  Dickey
 Jessica  Hatfield
 Robert  Kohn
 Arvind  Pandalai
 Mark  Quinn
 Dale  Shepherd
 David  Sonnenberg
 Mike  Starkie
 
  S & P Disclaimer
 

Clenergen Corp.
Symbol:  CRGE


Click here for a printable version
 
Capitalization as of 01/31/2010:
 
 Authorized SharesOutstanding Shares
Preferred $0.001 par10,000,000None
Common $0.001 par150,000,00091,586,013so2
 
LONG TERM DEBT: None.
 
Common $0.001 par
 
Stockholders:  12/01/2009, 112.
PRINCIPAL STOCKHOLDERS: November 5, 2009, Mark Quinn and Jessica Hatfield each owned 17.4% of the Common.
 
Transfer Agent:  Holladay Stock Transfer, Inc.   Scottsdale , AZ
 
OTC Bulletin Board( Primary): CRGE
 
ExchangeYearHighLow
OTC Bulletin Board20091.40000.5900
 
DIVIDENDS: Common $0.001 par: No cash. Common split 5.25-for-1, ex-Mar. 23, 2009. Common $0.001 par was split 21-for-4, ex-Mar. 23, 2009.
 
 
  so2As of Mar. 31, 2010.
  S & P Disclaimer
 

Clenergen Corp.
Symbol:  CRGE


Click here for a printable version
Annual Report
 
Income Statement
  20092008
GENERAL AND ADMINISTRATIVE EXPENSES1,072,695797
RESEARCH & DEVELOPMENT-175
Net income(1,072,695)(972)
Basic and Diluted EPS(0.0512)(0.1296)
 
Balance Sheet
  20092008
ASSETS
CURRENT ASSETS
Cash & equiv.1,47213
Prepaid Expenses and Other 15,039-
Tot. curr assets16,51113
Property & Equipment, Net12,901-
Deposits33,487-
Total assets62,89913
Liabilities:
CURRENT LIABILITIES
Accounts Payable and Accrued Expenses214,211-
Payroll Liabilities6,745-
Due to Affiliates and Shareholders330,3023,460,014
Total Current Liabilities551,2583,460,014
Common Stock86,94114,242
Additional paid in capital3,998,562-
Accumulated Other Comprehensive Income/(Loss)389,956416,880
Accumulated deficit during development stage(4,963,818)(3,891,123)
Total Stockholders' Deficiency(488,359)(3,460,000)
Total liabs.62,89913
 
 * Represents operations of Clenergen Corp. Ltd.
 
  S & P Disclaimer
 

Clenergen Corp.
Symbol:  CRGE


Click here for a printable version
Interim Report   
 
Data Not Available
 
 
 
 
  S & P Disclaimer
 

Clenergen Corp.
Symbol:  CRGE


Click here for a printable version
Pro Forma Report   
 
Data Not Available
 
 
 
 
  S & P Disclaimer
 

Clenergen Corp.
Symbol:  CRGE


Click here for a printable version
Quarterly Report Information   
 
Quarterly Revenue, US$
YearQuarterRevenue
  2010   1Nil
  2010   2Nil
  2009   1Nil
  2009   2Nil
  2009   3Nil
  2009   Full Year Nil
  2008   1Nil
  2008   2Nil
  2008   3Nil
  2008   Full Year Nil
  2007   1Nil
  2007   2Nil
  2007   3Nil
  2006   1Nil
  2006   2Nil
  2006   3Nil
 
 
Quarterly Net Income, US$
YearQuarterRevenue
  2010   1Nil
  2010   2Nil
  2009   1Nil
  2009   2Nil
  2009   3Nil
  2009   Full Year (1,070,000)
  2008   10
  2008   20
  2008   30
  2008   Full Year (10,000)
  2007   10
  2007   20
  2007   3(10,000)
  2007   Full Year (20,000)
  2006   1(10,000)
  2006   20
  2006   30
  2006   Full Year (10,000)
 
 
Quarterly EPS, US$
YearQuarterRevenue
  2010   1(.02)
  2010   2(.17)
  2009   1Nil
  2009   2Nil
  2009   3Nil
  2009   Full Year (.05)
  2008   1Nil
  2008   2Nil
  2008   3Nil
  2008   Full Year Nil
  2007   1Nil
  2007   2Nil
  2007   3Nil
  2007   Full Year (.01)
  2006   1(.01)
  2006   2Nil
  2006   3Nil
  2006   Full Year Nil
 
  S & P Disclaimer